CEO, Pres at Aim Immunotech Inc. Buys $4,992 in Stock

Thomas Equels K, who serves as CEO, Pres at Aim Immunotech Inc. (AIM), purchased 24,000 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The transaction was executed at a price of $0.21 per share, for a total value of approximately $4,992.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Insider buying is sometimes viewed by investors as a signal of confidence in a company's prospects, though a single transaction does not necessarily indicate a broader trend.